Ciancio, Gaetano <br/><br/>
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.  [electronic resource] 

 -  Transplantation  Jul 2008 
 - 67-74 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e3181734b4a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenal Cortex Hormones--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antilymphocyte Serum<br/>Daclizumab<br/>Drug Therapy, Combination<br/>Female<br/>Graft Rejection--prevention & control<br/>Graft Survival--drug effects<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney Function Tests<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--administration & dosage<br/>Tablets, Enteric-Coated<br/>Tacrolimus--therapeutic use<br/>Time Factors<br/>Treatment Outcome